A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

NCT03015844 · clinicaltrials.gov ↗

AVAILABLE

Status

OTHER

Sponsor class

Conditions

Neuroblastoma
Pheochromocytoma

Interventions

DRUG: 131-I-meta-iodobenzylguanidine

Sponsor

Northwell Health

Collaborators

[object Object]